Right to Try for Individualized Treatments Act

Access to individualized genomic treatments

If enacted, this bill would let patients with life‑threatening or severely debilitating illnesses request experimental drugs or personalized genomic treatments. For the investigational drug path, you would need a life‑threatening diagnosis, exhausted approved options, inability to join a clinical trial, and written informed consent. For genomic individualized treatments, a physician must certify approved options were considered, must be in good standing and not directly paid by the manufacturer, and you would provide written consent or a special additional consent signed by the doctor and a witness that lists treatment details and likely outcomes. Treatments must be offered at a health care facility operating under federal human‑subject protections, manufacturers could make treatments available but would not be required to, and existing investigational‑drug exemptions would be expanded to cover individualized treatments.